268 related articles for article (PubMed ID: 34492685)
1. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.
Prabahran A; Koldej R; Chee L; Ritchie D
Blood Adv; 2022 Mar; 6(6):1947-1959. PubMed ID: 34492685
[TBL] [Abstract][Full Text] [Related]
2. Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation.
Fraint E; Farooki S; Klein E; Mauguen A; Prockop SE; Scaradavou A; Curran K; Cancio M; Spitzer B; Boelens JJ; Oved J; Harris A; O'Reilly RJ; Kernan NA
Transplant Cell Ther; 2023 Jan; 29(1):46.e1-46.e6. PubMed ID: 36210027
[TBL] [Abstract][Full Text] [Related]
3. Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.
Prabahran A; Koldej R; Chee L; Szer J; Ritchie D
Bone Marrow Transplant; 2022 Oct; 57(10):1489-1499. PubMed ID: 35871087
[TBL] [Abstract][Full Text] [Related]
4. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights
Kong Y
Semin Hematol; 2019 Jul; 56(3):215-220. PubMed ID: 31202433
[TBL] [Abstract][Full Text] [Related]
5. Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation.
Man Y; Lu Z; Yao X; Gong Y; Yang T; Wang Y
Front Immunol; 2022; 13():911174. PubMed ID: 35720412
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation.
Prabahran A; Koldej R; Chee L; Wong E; Ritchie D
Leuk Lymphoma; 2021 Jun; 62(6):1482-1489. PubMed ID: 33522344
[TBL] [Abstract][Full Text] [Related]
7. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
[TBL] [Abstract][Full Text] [Related]
8. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
Kong Y; Chang YJ; Wang YZ; Chen YH; Han W; Wang Y; Sun YQ; Yan CH; Wang FR; Liu YR; Xu LP; Liu DH; Huang XJ
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1465-73. PubMed ID: 23879970
[TBL] [Abstract][Full Text] [Related]
9. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
[TBL] [Abstract][Full Text] [Related]
10. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
11. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
[TBL] [Abstract][Full Text] [Related]
12. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
13. Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes.
Koldej RM; Prabahran A; Tan CW; Ludford-Menting M; Morgan H; Holzwart N; Davis MJ; Ritchie DS
Front Immunol; 2023; 14():1213560. PubMed ID: 37818364
[TBL] [Abstract][Full Text] [Related]
14. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
Olsson RF; Logan BR; Chaudhury S; Zhu X; Akpek G; Bolwell BJ; Bredeson CN; Dvorak CC; Gupta V; Ho VT; Lazarus HM; Marks DI; Ringdén OT; Pasquini MC; Schriber JR; Cooke KR
Leukemia; 2015 Aug; 29(8):1754-62. PubMed ID: 25772027
[TBL] [Abstract][Full Text] [Related]
15. Graft failure after allogeneic hematopoietic stem cell transplantation.
Ozdemir ZN; Civriz Bozdağ S
Transfus Apher Sci; 2018 Apr; 57(2):163-167. PubMed ID: 29724627
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
Luft T; Dreger P; Radujkovic A
Bone Marrow Transplant; 2021 Oct; 56(10):2326-2335. PubMed ID: 34253879
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation.
Song Y; Zhao HY; Lyu ZS; Cao XN; Shi MM; Wen Q; Tang FF; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1981-1989. PubMed ID: 29933074
[TBL] [Abstract][Full Text] [Related]
18. Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: A systematic review and meta-analysis.
Müskens KF; Lindemans CA; Dandis R; Nierkens S; Belderbos ME
Blood Rev; 2023 Jul; 60():101076. PubMed ID: 36990959
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
Müskens KF; Lindemans CA; Belderbos ME
Cells; 2021 Aug; 10(8):. PubMed ID: 34440819
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
